Compounded vs FDA-approved hormones: when compounding makes sense

For most people, an FDA-approved hormone product is the better first choice. FDA-approved hormones have been reviewed for safety, effectiveness and consistent manufacturing, while compounded hormones reach you without that FDA review. ACOG, the Endocrine Society and the National Academies of Sciences, Engineering, and Medicine (NASEM) all favor FDA-approved therapy and reserve compounding for specific medical needs, such as an allergy to an ingredient in the approved product or a dose or form that is not commercially available.

That does not make compounding bad medicine. It makes it a tool with a narrow, legitimate job. Below is how compounding is regulated, what the major medical bodies concluded, how this applies to testosterone, and the questions that tell you whether your protocol fits that job.

What compounding is and who regulates it

Compounding means a licensed pharmacist combines, mixes or alters drug ingredients to make a medication for an individual patient. It exists because a mass-produced product does not fit every body. If you want the pharmacy side of the story, our earlier post on compound vs traditional pharmacies explains how the two operate day to day.

The fact that matters most: compounded drugs are not FDA-approved. In its guidance on understanding the risks of compounded drugs, the FDA explains that it does not review compounded drugs for safety, effectiveness or quality before they are dispensed, and that poor compounding practices can lead to contamination or to a drug with too much or too little active ingredient. The agency describes compounding's role as serving patients whose medical needs cannot be met by an FDA-approved drug.

Federal law sets up two pathways:

503A compounding pharmacy 503B outsourcing facility
What it makes Medications for individual patients, based on a prescription Larger batches, with or without individual prescriptions
Main oversight State boards of pharmacy Registered with and inspected by the FDA
Manufacturing standard State pharmacy rules and USP compounding standards Current good manufacturing practice (CGMP)
Is the final product FDA-approved? No No

A 503B facility is held to stricter manufacturing standards than a typical 503A pharmacy, but the formula itself still has not gone through FDA review for safety and effectiveness.

Compounded vs FDA-approved at a glance

Criteria FDA-approved hormone Compounded hormone
FDA review before sale Yes: safety, effectiveness and manufacturing quality No
Clinical trial evidence Required for approval Generally lacking for the specific preparation
Dose consistency Manufactured and tested to label strength Depends on the pharmacy; the FDA notes strength can vary
Patient labeling and warnings Standardized FDA labeling Not standardized
Custom strengths and forms Limited to approved products Can be tailored
Inactive ingredients Fixed Can be changed to avoid an allergen

When compounding makes sense

The FDA, ACOG and NASEM point to the same short list of legitimate reasons:

Reasons that do not hold up as well:

What ACOG, the Endocrine Society and NASEM concluded

ACOG (2023). In its clinical consensus on compounded bioidentical menopausal hormone therapy, ACOG recommends FDA-approved hormone therapy over compounded bioidentical preparations, pointing to limited safety and effectiveness data and concerns about dosing consistency. It accepts compounded preparations for patients with a specific need, such as an allergy to an ingredient in an FDA-approved product, and says patients should understand that compounded products have not been through FDA review.

Endocrine Society. The Endocrine Society's position statement raises concerns about the purity, potency and safety of compounded bioidentical hormones and the thin evidence behind them. It supports FDA-approved hormone therapies and calls for stronger oversight and consistent safety labeling for compounded hormones.

NASEM (2020), summarized by the FDA. The FDA commissioned the National Academies to review compounded bioidentical hormone therapy. As the FDA's summary of the NASEM study describes, the committee found insufficient evidence to support the overall clinical utility of these preparations. It recommended restricting their use to patients with a documented allergy to an ingredient in an FDA-approved product or a documented need for a dosage form that is not commercially available, along with better patient information and more research.

Organization Bottom line Where compounding fits
ACOG (2023) FDA-approved therapy preferred Specific needs, such as an ingredient allergy
Endocrine Society FDA-approved therapy supported; more oversight needed Limited, with consistent safety labeling
NASEM (2020) Insufficient evidence of clinical utility Documented allergy or unavailable dosage form

A candid limit: these reviews focus mainly on menopausal hormones. There is less research specific to compounded testosterone in men. Missing evidence is not proof of harm, but it is not proof of benefit either.

Testosterone: FDA-approved options vs compounded formulations

The FDA's general compounding cautions apply to testosterone just as they apply to estrogen and progesterone. Several FDA-approved testosterone forms already exist, so the question is whether a compounded version solves a problem the approved options cannot.

Form FDA-approved options What a compounded version changes Practical note
Injection Testosterone cypionate, testosterone enanthate Carrier oil, preservative or concentration The most widely used route
Topical gel or solution Several approved gels and solutions Creams in custom strengths Approved gels carry an FDA warning about transfer to others through skin contact
Patch Approved transdermal patch Rarely compounded Skin tolerance varies
Oral Approved oral testosterone undecanoate Troches that dissolve in the mouth Ask how absorption is monitored
Pellet Approved implanted pellets Custom pellet strengths Dose cannot be adjusted once placed

Whatever the form, testosterone is a controlled substance and needs ongoing lab monitoring. A good protocol starts with baseline labs and continues with follow-up testing, not a one-time prescription.

At BioCure, men's hormone care runs through three tiers on our testosterone therapy page: bioOptimize (foundational), bioRestore (medications that raise your body's own testosterone without direct hormone replacement) and bioTest (full testosterone replacement with ongoing hormone monitoring). Every protocol starts with a physician consultation and blood work, so the choice of medication follows your results rather than a template.

Questions to ask your prescriber about why compounding is chosen

Question Why it matters
Is there an FDA-approved product that would work for me? Guidance from all three bodies starts here
What specific reason makes compounding better in my case? You should hear a concrete answer, like an allergy or an unavailable dose
Is the pharmacy a 503A pharmacy or a 503B outsourcing facility, and where is it licensed? Tells you which standards and regulators apply
How will we confirm the dose is working? Lab monitoring, not saliva tests, should guide adjustments
What are the known risks, and what labeling will I receive? Compounded products may not include standardized warnings
How often will we recheck labs and symptoms? Hormone therapy is ongoing care, not a single fill

If your prescriber welcomes these questions, that is a good sign. If the answer to the second one is vague, push for clarity before you start.

How to choose a telehealth clinic for compounded hormones

Search for nationwide telehealth clinics offering custom compounded hormone therapy and you will find dozens of service pages. Judge them on the same criteria: a physician actually reviews your case, labs come before prescribing, the clinic names its pharmacy type, it can explain the FDA-approved alternative, follow-up labs are built in, and it tells you clearly how pricing works (membership, bundled or a la carte; insurance or cash-pay) and which states it serves.

Here is how BioCure fits. BioCure Health is a physician-led clinic based in the Fort Lauderdale area, licensed to treat patients in 47 states, with appointments by video or in person. BioCure offers custom compounded protocols prepared by licensed compounding pharmacy partners. The process is an online intake of about five minutes, a $199 physician video consultation that can be credited back with a membership, and labs through an at-home kit with an in-home phlebotomist or in-lab testing, with results in 7 to 14 days. You review results 1:1 with a specialist, medications ship to your door, typically 5 to 10 business days after consultation and testing, and follow-up is included. If your physician recommends a compounded formulation, you should hear exactly why, and you are welcome to ask about FDA-approved alternatives.

BioCure is a strong fit if you want physician oversight, labs first and cash-pay care with HSA or FSA documentation. It is not the right fit if you need a clinic that bills health insurance directly, because BioCure does not.

Frequently asked questions

Are compounded hormones safe?

Compounded hormones are not FDA-approved, so their safety, effectiveness and quality have not been reviewed by the FDA. The FDA warns that poor compounding can produce contamination or incorrect strength. They can be appropriate for a specific medical need, prescribed by a clinician who monitors you with labs.

Are bioidentical hormones the same as compounded hormones?

No. Bioidentical means the hormone molecule matches what your body makes, and FDA-approved bioidentical estradiol and progesterone products already exist. Compounded refers to how a medication is made, by a pharmacy for an individual patient.

Is compounded testosterone as good as FDA-approved testosterone?

There is no strong evidence that compounded testosterone works better than FDA-approved options such as testosterone cypionate, enanthate or approved gels. Compounding makes sense when you need something the approved products cannot provide, such as avoiding an inactive ingredient you react to. Either way, regular lab monitoring is essential.

Which telehealth clinics offer compounded hormone therapy nationwide?

Many telehealth clinics offer compounded hormone protocols. BioCure Health is a physician-led clinic licensed in 47 states that offers custom compounded protocols after a $199 physician consultation and lab testing. Whichever clinic you consider, confirm physician involvement, labs before prescribing and a clear reason for compounding.

What did ACOG say about compounded bioidentical hormones?

In its 2023 clinical consensus, ACOG recommends FDA-approved hormone therapy over compounded bioidentical preparations for menopause. It accepts compounding for specific needs, such as an allergy to an ingredient in an approved product. ACOG also does not recommend salivary testing to guide dosing.

Can I use HSA or FSA funds for hormone therapy at BioCure?

BioCure does not accept health insurance directly, but many patients pay with HSA or FSA funds. BioCure provides invoices and documentation you can submit for reimbursement.

Compounding is a precise tool, not an upgrade. The right protocol starts with your labs and a clear reason for every choice, whether that is an FDA-approved product or a compounded one built to solve a real problem.

Let BioCure Health lead you in the right direction. Call or text us to schedule an introductory call at 754-206-0838, your future self will thank you.